Human Kallikrein 12 Antibody

Catalog #: MAB40341
3 Citations Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
MAB40341
MAB40341-SP

Neutralization of Kallikrein 12 Activity by Human Kallikrein 12 Antibody.

1 Image

Product Details

Citations (3)

Supplemental Products

Reviews

Summary Data Examples Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human Kallikrein 12 Antibody Summary

Species Reactivity

Human

Specificity

Detects human Kallikrein 12 in direct ELISAs and Western blots. No cross-reactivity with recombinant human (rh) Kallikrein 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 15, rhKallikrein beta 1, rhHGF Activator, rhFactor VII, rhFactor X, rhFactor XI, rhThrombin or rhuPA-1 is observed.

Source

Monoclonal Mouse IgG_2B Clone # 364932

Purification

Protein A or G purified from hybridoma culture supernatant

Immunogen

Mouse myeloma cell line NS0-derived recombinant human Kallikrein 12
Ala18-Asn248
Accession # Q9UKR0

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Applications

Recommended Concentration

Sample

Western Blot

1 µg/mL

Recombinant Human Kallikrein 12 (Catalog # 3095-SE) under non-reducing conditions only

Immunoprecipitation

25 µg/mL

Conditioned cell culture medium spiked with Recombinant Human Kallikrein 12 (Catalog # 3095-SE), see our available Western blot detection antibodies

Neutralization

Measured by its ability to neutralize Recombinant Human Kallikrein 12 (0.1 µg/mL, Catalog # 3095-SE) cleavage of the fluorogenic peptide substrate Boc-VPR-AMC (0.1 mM, Catalog # ES011). The Neutralization Dose (ND₅₀) is typically 0.1 µg/mL.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Neutralization

View Larger

Neutralization of Kallikrein 12 Activity by Human Kallikrein 12 Antibody. The cleavage of Boc-VPR-AMC (0.1 mM, Catalog # ES011) by Recombinant Human Kallikrein 12 (0.1 µg/mL, Catalog # 3095-SE) is measured after preincubation with increasing concentrations of Human Kallikrein 12 Monoclonal Antibody (Catalog # MAB40341). The ND₅₀ is typically 0.1 µg/mL.

Reconstitution Calculator

Preparation and Storage

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Kallikrein 12

Human tissue Kallikrein 12, encoded by the KLK12 gene, is a secreted serine protease that belongs to the human tissue kallikrein family (1). It is present in many tissues, such as salivary gland, stomach and breast. KLK12 displays trypsin-like enzymatic activity. This activity can be inhibited by Serpin F2 (R&D Systems, Catalog # 1470-PI). The physiological functions of KLK12 still remain unclear. Its expression is modulated by steroid hormones and is down‑regulated in breast cancer (2). Human KLK12 has three splice variants resulting from alternative splicing of the 3’ end. The amino acid sequence of human KLK12 is 80%, 77%, 71% and 66% to that of bovine, canine, mouse, and rat.

References

Yousef, G.M. et al. (2000) Genomics. 69:331.
Yousef, G.M. and E.P. Diamandis (2001) Endocrine Rev. 22:184.

Entrez Gene IDs

43849 (Human)

Alternate Names

DKFZp686H1078; EC 3.4.21; EC 3.4.21.-; Kallikrein 12; Kallikrein-like protein 5; kallikrein-related peptidase 12; KLK12; KLK-L5; KLKL5kallikrein-12; KLK-L5MGC42603

Product Datasheets

Product Datasheet

COA

SDS

Related Research Areas

Citations for Human Kallikrein 12 Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

3 Citations: Showing 1 - 3
Filter your results:

Filter by:

Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker
Authors: Sato, A;Takagi, K;Yoshimura, A;Tsukamoto, W;Yamaguchi-Tanaka, M;Miki, Y;Ebata, A;Miyashita, M;Suzuki, T;
International journal of molecular sciences
Species: Human
Sample Types: Whole Tissue
Applications: IHC
Inhibition of transcription factor specificity protein 1 alters the gene expression profile of keratinocytes leading to upregulation of kallikrein-related peptidases and thymic stromal lymphopoietin.
Authors: Bin L, Kim BE, Hall CF
J. Invest. Dermatol., 2011-07-14;131(11):2213-22.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization
Enzymatic properties of human kallikrein-related peptidase 12 (KLK12).
Authors: Memari</LastName><ForeNam N</Initial, Memari N, Jiang W, Diamandis EP, Luo LY
Biol. Chem., 2007-04-01;388(4):427-35.
Species: Human
Sample Types: Recombinant Protein
Applications: Neutralization